Electrical spinal cord stimulation in painful diabetic polyneuropathy, a systematic review on treatment efficacy and safety (Q37846329)

24 August 2017

1 reference

title

Electrical spinal cord stimulation in painful diabetic polyneuropathy, a systematic review on treatment efficacy and safety (English)

1 reference

24 August 2017

1 reference

diabetic polyneuropathy

1 reference

Wouter A Pluijms

1

1 reference

24 August 2017

Rachel Slangen

2

1 reference

24 August 2017

Elbert A Joosten

3

1 reference

24 August 2017

Alfons G Kessels

4

1 reference

24 August 2017

Ingemar S J Merkies

5

1 reference

24 August 2017

Nico C Schaper

6

1 reference

24 August 2017

Catharina G Faber

7

1 reference

24 August 2017

Maarten van Kleef

8

1 reference

24 August 2017

22 February 2011

1 reference

24 August 2017

European Journal of Pain

1 reference

24 August 2017

15

1 reference

24 August 2017

8

1 reference

24 August 2017

783-788

1 reference

Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial.

24 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2011.01.010

Continuous subcutaneous insulin infusion in the management of painful diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2011.01.010

Polyol pathway activation and glutathione redox status in non-insulin-dependent diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2011.01.010

Preventing superoxide formation in epineurial arterioles of the sciatic nerve from diabetic rats restores endothelium-dependent vasodilation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2011.01.010

Electrical spinal cord stimulation in the long-term treatment of chronic painful diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2011.01.010

Chronic painful peripheral neuropathy in an urban community: a controlled comparison of people with and without diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2011.01.010

The prevalence, severity, and impact of painful diabetic peripheral neuropathy in type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2011.01.010

Effect and safety of spinal cord stimulation for treatment of chronic pain caused by diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2011.01.010

Oxcarbazepine in painful diabetic neuropathy: a randomized, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2011.01.010

Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2011.01.010

Lamotrigine reduces painful diabetic neuropathy: a randomized, controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2011.01.010

Immune dysfunction in patients with diabetes mellitus (DM).

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2011.01.010

Morphine, gabapentin, or their combination for neuropathic pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2011.01.010

Controlled-release oxycodone for pain in diabetic neuropathy: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2011.01.010

Duloxetine vs. placebo in patients with painful diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2011.01.010

Burden of illness in painful diabetic peripheral neuropathy: the patients' perspectives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2011.01.010

Grading strength of recommendations and quality of evidence in clinical guidelines: report from an american college of chest physicians task force

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2011.01.010

New perspectives on the management of diabetic peripheral neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2011.01.010

Duloxetine for the management of diabetic peripheral neuropathic pain: evidence-based findings from post hoc analysis of three multicenter, randomized, double-blind, placebo-controlled, parallel-group studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2011.01.010

Effect of spinal cord stimulation for chronic complex regional pain syndrome Type I: five-year final follow-up of patients in a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2011.01.010

The effect of spinal cord stimulation in patients with chronic reflex sympathetic dystrophy: two years' follow-up of the randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2011.01.010

The effects of spinal cord stimulation in neuropathic pain are sustained: a 24-month follow-up of the prospective randomized controlled multicenter trial of the effectiveness of spinal cord stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2011.01.010

Spinal cord stimulation versus conventional medical management for neuropathic pain: a multicentre randomised controlled trial in patients with failed back surgery syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2011.01.010

Spinal cord stimulation for chronic pain in peripheral neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2011.01.010

Pregabalin relieves symptoms of painful diabetic neuropathy: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2011.01.010

The relationship between blood glucose excursions and painful diabetic peripheral neuropathy: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2011.01.010

Meta-analysis of duloxetine vs. pregabalin and gabapentin in the treatment of diabetic peripheral neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2011.01.010

Duloxetine versus routine care in the long-term management of diabetic peripheral neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2011.01.010

Duloxetine for patients with diabetic peripheral neuropathic pain: a 6-month open-label safety study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2011.01.010

Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2011.01.010

The selective serotonin reuptake inhibitor paroxetine is effective in the treatment of diabetic neuropathy symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2011.01.010

Clomipramine vs desipramine vs placebo in the treatment of diabetic neuropathy symptoms. A double-blind cross-over study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2011.01.010

Antidepressants in the treatment of neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2011.01.010

Meta-analysis of Observational Studies in Epidemiology: A Proposal for Reporting

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2011.01.010

Impaired blood flow and arterio-venous shunting in human diabetic neuropathy: a novel technique of nerve photography and fluorescein angiography

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2011.01.010

Electrical spinal-cord stimulation for painful diabetic peripheral neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2011.01.010

Glycation in diabetic neuropathy: characteristics, consequences, causes, and therapeutic options

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2011.01.010

Controlled-release oxycodone relieves neuropathic pain: a randomized controlled trial in painful diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2011.01.010

A randomized controlled trial of duloxetine in diabetic peripheral neuropathic pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2011.01.010

An open-label 52-week clinical extension comparing duloxetine with routine care in patients with diabetic peripheral neuropathic pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2011.01.010

Global prevalence of diabetes: estimates for the year 2000 and projections for 2030

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2011.01.010

Diabetes mellitus and the peripheral nervous system: manifestations and mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2011.01.010

10.1016/J.EJPAIN.2011.01.010

21 January 2018

Identifiers

DOI

1 reference

24 August 2017

1 reference